| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +16,666,666 | 99% | $21.00 | +$349,999,986 |
| Sells | 9 | -176,810 | 1% | $18.96 | -$3,351,558 |
| Net | -8 | +16,489,856 | 98% | +$346,648,428 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Roivant Sciences Ltd. | Director, 10%+ Owner | $2,379,657,147 | +$349,999,986 | +17% | 12 Dec 2025 |
| Peter Salzmann | Chief Executive Officer, Director | $17,543,264 | -$810,898 | -4.4% | 16 Apr 2025 |
| Frank Torti | Director | $16,667,378 | 01 Apr 2025 | ||
| Julia G. Butchko | Chief Development Officer | $14,251,795 | 21 Aug 2024 | ||
| Mark S. Levine | Chief Legal Officer | $8,124,353 | 20 Nov 2024 | ||
| William L. Macias | Chief Medical Officer | $7,454,384 | -$42,867 | -0.57% | 19 Feb 2025 |
| Eva Renee Barnett | Chief Financial Officer | $5,907,965 | -$246,974 | -4% | 16 Apr 2025 |
| Jay S. Stout | Chief Technology Officer | $5,373,528 | -$328,056 | -5.8% | 07 Jan 2026 |
| Melanie Gloria | Chief Operating Officer | $4,159,058 | -$298,237 | -6.7% | 20 Nov 2025 |
| Michael Geffner | Chief Medical Officer | $4,147,740 | -$310,958 | -7% | 22 Oct 2025 |
| Christopher Van Tuyl | Chief Legal Officer | $4,105,083 | -$290,943 | -6.6% | 18 Dec 2025 |
| Tiago Girao | Chief Financial Officer | $3,059,135 | 01 May 2025 | ||
| Douglas J. Hughes | Director | $2,893,721 | -$348,665 | -11% | 01 Dec 2025 |
| GEORGE MIGAUSKY V. | Director | $2,739,530 | 01 Apr 2025 | ||
| Atul Pande | Director | $2,452,106 | 01 Apr 2025 | ||
| Andrew J. Fromkin | Director | $2,056,155 | -$673,958 | -25% | 01 Dec 2025 |
| Jake Bauer | Director | $367,234 | 01 May 2025 | ||
| Robert Graham Susman | Director | $367,234 | 01 May 2025 | ||
| Eric Venker | Chief Executive Officer, Director | 28 Jul 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|